Pfizer Vaccine on Track for Regulatory Review in October – Bloomberg

Pfizer Inc. and
BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from an ear… [+2525 chars]